Discover comprehensive details about Brexanolone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...
HealthDay News — For patients with super-refractory status epilepticus (SRSE), brexanolone as adjunctive therapy is tolerated and associated with a high rate of third-line agent (TLA) weaning, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders ...
Review the side-effects of Brexanolone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Researchers uncover mechanisms of brexanolone and the role of inflammation in post-partum depression
CHAPEL HILL, N.C. – Post-partum depression (PPD) develops after childbirth and affects both the mother's and the infant's health by preventing healthy bonding. Women with PPD experience intense ...
A joint US Food and Drug Administration (FDA) advisory panel voted in favor of approval for brexanolone intravenous infusion (Zulresso, Sage Therapeutics) as the first-ever drug indicated for the ...
postpartum depression Clinical trials were conducted to assess the effect brexanolone and zuranolone, neuroactive steroids that are positive allosteric modulators of the gamma-aminobutyric acid ...
Brexanolone IV received Breakthrough Therapy Designation in September 2016, underscoring the significant unmet need in women with PPD. Breakthrough Therapy Designation is intended to offer a ...
The committees also unanimously agreed that Sage Therapeutics presented “substantial evidence” to support its claim of brexanolone’s effectiveness for postpartum depression and voted 16-2 that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback